Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.

about

Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.

P2860

Q39279968-9D004BDB-B536-4E18-AB3D-BBF6CBFCBFAF Q49592680-3DB0809F-34E7-4802-9D81-65C3CBA5660D

P2860

Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.

Item

http://www.wikidata.org/entity/Q42129626

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antibody production using a ci ...... nhanced cell-killing activity.

@en

Antibody production using a ci ...... nhanced cell-killing activity.

@nl

type

Item

label

Antibody production using a ci ...... nhanced cell-killing activity.

@en

Antibody production using a ci ...... nhanced cell-killing activity.

@nl

prefLabel

Antibody production using a ci ...... nhanced cell-killing activity.

@en

Antibody production using a ci ...... nhanced cell-killing activity.

@nl

P1476

Antibody production using a ci ...... nhanced cell-killing activity.

@en

P2093

Anna-Janina Behrens

http://www.w3.org/2001/XMLSchema#string

Daniel Schinor

http://www.w3.org/2001/XMLSchema#string

David J Harvey

http://www.w3.org/2001/XMLSchema#string

Jenny Calow

http://www.w3.org/2001/XMLSchema#string

Kai U Cormann

http://www.w3.org/2001/XMLSchema#string

Karin Loser

http://www.w3.org/2001/XMLSchema#string

Marcus W W Hartmann

http://www.w3.org/2001/XMLSchema#string

Sonja Mader

http://www.w3.org/2001/XMLSchema#string

Ulrike Bockau

http://www.w3.org/2001/XMLSchema#string

P2860

Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote

Tetrahymena Genome Database (TGD): a new genomic resource for Tetrahymena thermophila research.

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions

Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis

Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions

Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy

Antibodies to watch in 2015

The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

P304

1498-1511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19420862.2016.1228504

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27594301

http://www.w3.org/2001/XMLSchema#string

P932

5098438

http://www.w3.org/2001/XMLSchema#string

Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.

about

P2860

P2860

Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932